Calciscon

SHORT DESCRIPTION:

Calcification Propensity Diagnostics to Prevent Cardiovascular Disease. Cardiovascular disease (CVD) is the leading cause of death, and vascular calcification is a most important driver of CVD. Calciscon T50® test offers unprecedented clinical information of the patient’s calcification, and the T50-derived algorithm predicts the most effective drug to effectively slow down calcification: T50 could prevents up to half of the cardiovascular events in the patient group most affected by vascular calcification.

LONG DESCRIPTION: